Home

Market Capitalization of Aarti Pharmalabs Ltd

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Market Cap

₹ 5637.84 crore

Last updated on: Jan 24, 2025

Key Highlights

  • The Market Cap of Aarti Pharmalabs Ltd is ₹ 5637 crore as of 24 Jan 25 .
  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 600.6 as of 27 Jan 09:36 .
  • The Dividend Payouts of Aarti Pharmalabs Ltd changed from ₹ 2 on Feb 16, 2024 to ₹ 1 on Jul 31, 2024 . This represents a CAGR of -29.29% over 2 years.
Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

Share Price

₹ 600.6

-21.50 (-3.46%)

stock direction

Last updated on: Jan 27, 2025

Market Price of Aarti Pharmalabs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Jan 2025622.1
23 Jan 2025638
22 Jan 2025638.7
21 Jan 2025661.9
20 Jan 2025679.05
17 Jan 2025655.8
16 Jan 2025659.45
15 Jan 2025654.75
14 Jan 2025652.25
13 Jan 2025659.95

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Aarti Pharmalabs Ltd

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Aarti Pharmalabs Ltd

No data available

No data available

Historical P/E Ratio of Aarti Pharmalabs Ltd

No data available

* All values are in %

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Aarti Pharmalabs Ltd

No data available

* All values are in

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

Aarti Pharmalabs Ltd News Hub

Aarti Pharmalabs consolidated net profit rises 17.75% in the June 2024 quarter

Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 2024 as again

Read more

05 Aug 24

Aarti Pharmalabs to discuss results

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 October 2024. Po

Read more

22 Oct 24

Aarti Pharmalabs consolidated net profit rises 5.44% in the September 2024 quarter

Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as a

Read more

28 Oct 24

Aarti Pharmalabs Company Secretary resigns

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the position o

Read more

28 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Aarti Pharmalabs Ltd Market Cap

What is the market cap of Aarti Pharmalabs Ltd?

As of January 27, 2025, Aarti Pharmalabs Ltd has a market capitalization of ₹5637.84, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aarti Pharmalabs Ltd's market capitalization?

Aarti Pharmalabs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aarti Pharmalabs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aarti Pharmalabs Ltd's market capitalization change?

Aarti Pharmalabs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions